Evidence map›Paper›PMID 24608875›Full record

ArticlePloS one2014

Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.

Bruce J Kirenga, Jonathan Levin, Irene Ayakaka, William Worodria, Nancy Reilly, Francis Mumbowa, Helen Nabanjja, Grace Nyakoojo, Kevin Fennelly, Susan Nakubulwa and 9 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. A predictive score for early in-patient tuberculosis mortality: A case-control study.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Bruce J KirengaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Jonathan LevinMedical Research Council-Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda; School of Public Health, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Irene AyakakaMakerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.
William WorodriaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Nancy ReillyDepartment of Medicine, New Jersey Medical School - Rutgers University, Newark, New Jersey, United States of America.
Francis MumbowaDepartment of Microbiology, Makerere University College of Health Sciences, Kampala, Uganda.
Helen NabanjjaMakerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.
Grace NyakoojoMakerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.
Kevin FennellySoutheastern National Tuberculosis Center, Division of Mycobacteriology, Department of Medicine, University of Florida, Gainesville, Florida, United States of America; Makerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.
Susan NakubulwaMedical Research Council-Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda.
Moses JolobaDepartment of Microbiology, Makerere University College of Health Sciences, Kampala, Uganda.
Alphonse OkweraMedical Research Council-Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda; Mulago Hospital Tuberculosis Clinic, Mulago Hospital, Kampala, Uganda.
Kathleen D EisenachDepartments of Pathology and, Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Ruth McNerneyDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, England.
Alison M ElliottMedical Research Council-Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, England.
Roy D MugerwaDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda; Makerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.
Peter G SmithMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, England.
Jerrold J EllnerSection of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, United States of America; Makerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.
Edward C Jones-LópezSection of Infectious Diseases, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, United States of America; Makerere University - Boston Medical Center Research Collaboration, Kampala, Uganda.

Funding

Medical Research Council MR/K012126/1Wellcome Trust 063410/ABC/00/ZWellcome Trust 095778Wellcome Trust 100714
6 · The paper itself

Abstract

backgroundIn most resource limited settings, new tuberculosis (TB) patients are usually treated as outpatients. We sought to investigate the reasons for hospitalisation and the predictors of poor treatment outcomes and mortality in a cohort of hospitalized new TB patients in Kampala, Uganda. METHODS AND

findingsNinety-six new TB patients hospitalised between 2003 and 2006 were enrolled and followed for two years. Thirty two were HIV-uninfected and 64 were HIV-infected. Among the HIV-uninfected, the commonest reasons for hospitalization were low Karnofsky score (47%) and need for diagnostic evaluation (25%). HIV-infected patients were commonly hospitalized due to low Karnofsky score (72%), concurrent illness (16%) and diagnostic evaluation (14%). Eleven HIV uninfected patients died (mortality rate 19.7 per 100 person-years) while 41 deaths occurred among the HIV-infected patients (mortality rate 46.9 per 100 person years). In all patients an unsuccessful treatment outcome (treatment failure, death during the treatment period or an unknown outcome) was associated with duration of TB symptoms, with the odds of an unsuccessful outcome decreasing with increasing duration. Among HIV-infected patients, an unsuccessful treatment outcome was also associated with male sex (P = 0.004) and age (P = 0.034). Low Karnofsky score (aHR = 8.93, 95% CI 1.88 - 42.40, P = 0.001) was the only factor significantly associated with mortality among the HIV-uninfected. Mortality among the HIV-infected was associated with the composite variable of CD4 and ART use, with patients with baseline CD4 below 200 cells/µL who were not on ART at a greater risk of death than those who were on ART, and low Karnofsky score (aHR = 2.02, 95% CI 1.02 - 4.01, P = 0.045).

conclusionPoor health status is a common cause of hospitalisation for new TB patients. Mortality in this study was very high and associated with advanced HIV Disease and no use of ART.

Indexed as

AdultAnti-HIV AgentsFemaleHIV InfectionsHumansMaleProspective StudiesTreatment OutcomeTuberculosisUgandaYoung AdultAnti-HIV Agents

Identifiers

PMID24608875
PMCPMC3948371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.